Litcius/Paper detail

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Roland Meisel

2021New England Journal of Medicine57 citationsDOI

Topics & Concepts

CRISPRThalassemiaMedicineGenome editingHemoglobinopathyGeneticsDiseaseGeneCas9BiologyInternal medicineHemoglobinopathies and Related DisordersCRISPR and Genetic EngineeringPrenatal Screening and Diagnostics
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | Litcius